- Home
- ACXP vs FRSX Comparison
ACXP vs FRSX Comparison
Compare ACXP & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- FRSX
- Stock Information
- Founded
- ACXP 2017
- FRSX N/A
- Country
- ACXP United States
- FRSX Israel
- Employees
- ACXP N/A
- FRSX N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- FRSX Computer Software: Prepackaged Software
- Sector
- ACXP Health Care
- FRSX Technology
- Exchange
- ACXP Nasdaq
- FRSX Nasdaq
- Market Cap
- ACXP 31.4M
- FRSX 13.7M
- IPO Year
- ACXP 2021
- FRSX 2017
- Fundamental
- Price
- ACXP $0.46
- FRSX $0.75
- Analyst Decision
- ACXP Strong Buy
- FRSX
- Analyst Count
- ACXP 1
- FRSX 0
- Target Price
- ACXP $12.00
- FRSX N/A
- AVG Volume (30 Days)
- ACXP 472.4K
- FRSX 785.5K
- Earning Date
- ACXP 03-18-2025
- FRSX 03-26-2025
- Dividend Yield
- ACXP N/A
- FRSX N/A
- EPS Growth
- ACXP N/A
- FRSX N/A
- EPS
- ACXP N/A
- FRSX N/A
- Revenue
- ACXP N/A
- FRSX $473,000.00
- Revenue This Year
- ACXP N/A
- FRSX N/A
- Revenue Next Year
- ACXP N/A
- FRSX N/A
- P/E Ratio
- ACXP N/A
- FRSX N/A
- Revenue Growth
- ACXP N/A
- FRSX 3.28
- 52 Week Low
- ACXP $0.43
- FRSX $0.57
- 52 Week High
- ACXP $3.33
- FRSX $2.63
- Technical
- Relative Strength Index (RSI)
- ACXP 30.04
- FRSX 40.38
- Support Level
- ACXP $0.60
- FRSX $0.68
- Resistance Level
- ACXP $0.67
- FRSX $0.81
- Average True Range (ATR)
- ACXP 0.07
- FRSX 0.10
- MACD
- ACXP -0.03
- FRSX 0.00
- Stochastic Oscillator
- ACXP 6.99
- FRSX 21.98
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its advanced systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.